Literature DB >> 23348871

Postoperative urinary tract infection and short-term outcomes and costs in head and neck cancer surgery.

Jason Y K Chan1, Yevgeniy R Semenov, Christine G Gourin.   

Abstract

OBJECTIVES: Catheter-associated urinary tract infections (UTIs) have been identified as a preventable "never event" by the Centers for Medicare & Medicaid Services. We sought to determine the relationship between UTI and in-hospital mortality, postoperative complications, length of stay, and costs in head and neck cancer (HNCA) surgery. STUDY
DESIGN: Cross-sectional analysis using cross-tabulations and multivariate regression modeling.
SETTING: The Nationwide Inpatient Sample database. SUBJECTS AND METHODS: Discharge data for 93,663 patients who underwent an ablative procedure for a malignant oral cavity, laryngeal, hypopharyngeal, or oropharyngeal neoplasm in 2003-2008 were analyzed.
RESULTS: Urinary tract infection was diagnosed in 2% of patients, with catheter-associated UTI coded in only 20 patients. Patients with UTI were more likely to be older than 80 years (odds ratio [OR], 3.3; P = .008), be female (OR, 1.9; P < .001), have advanced comorbidity (OR, 1.8; P < .012), undergo major surgical procedures (OR, 1.7; P = .001), and have predisposing bladder and prostate conditions (OR, 3.8; P < .001), surgical complications (OR, 2.3; P < .001), and acute medical complications (OR, 3.1; P < .001). Urinary tract infection was associated with significantly increased length of hospitalization and hospital-related costs, after controlling for all other variables.
CONCLUSION: Urinary tract infection is unusual in HNCA surgical patients but is more common with extent of surgery and age and is significantly associated with postoperative complications, length of hospitalization, and hospital-related costs. Catheter-associated UTI is likely underestimated because of difficulty in distinguishing between a catheter-associated UTI and postoperative UTI in patients undergoing major surgical procedures, who routinely undergo perioperative urinary catheterization. Patients with HNCA are a high-risk group for this "never event," particularly as the population ages.

Entities:  

Mesh:

Year:  2013        PMID: 23348871     DOI: 10.1177/0194599812474595

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  Tobacco use and surgical outcomes in patients with head and neck cancer.

Authors:  Jeanne L Hatcher; Katherine R Sterba; Janet A Tooze; Terry A Day; Matthew J Carpenter; Anthony J Alberg; Christopher A Sullivan; Nora C Fitzgerald; Kathryn E Weaver
Journal:  Head Neck       Date:  2015-05-17       Impact factor: 3.147

Review 2.  Outcomes measurement in patients with head and neck cancer.

Authors:  Christine G Gourin
Journal:  Curr Oncol Rep       Date:  2014-03       Impact factor: 5.075

3.  Microvascular reconstruction in head and neck cancer - basis for the development of an enhanced recovery protocol.

Authors:  Jens H Højvig; Nicolas J Pedersen; Birgitte W Charabi; Irene Wessel; Lisa T Jensen; Jan Nyberg; Nana Mayman-Holler; Henrik Kehlet; Christian T Bonde
Journal:  JPRAS Open       Date:  2020-10-15

4.  Prevalence, impact, and risk factors for hospital-acquired conditions after major surgical resection for cancer: a NSQIP analysis.

Authors:  Daniela Molena; Benedetto Mungo; Miloslawa Stem; Richard L Feinberg; Anne O Lidor
Journal:  J Gastrointest Surg       Date:  2014-09-09       Impact factor: 3.452

Review 5.  The economic burden of head and neck cancer: a systematic literature review.

Authors:  Erika Wissinger; Ingolf Griebsch; Juliane Lungershausen; Talia Foster; Chris L Pashos
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.